Chicago Partners Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.42M | Buy |
96,817
+3,544
| +4% | +$92.7K | 0.05% | 303 |
|
|
2026
Q1 | $2.5M | Buy |
93,273
+11,016
| +13% | +$293K | 0.06% | 274 |
|
|
2025
Q4 | $2.11M | Sell |
82,257
-4,260
| -5% | -$107K | 0.05% | 281 |
|
|
2025
Q3 | $2.12M | Buy |
86,517
+8,947
| +12% | +$221K | 0.06% | 267 |
|
|
2025
Q2 | $1.97M | Buy |
77,570
+4,462
| +6% | +$104K | 0.06% | 258 |
|
|
2025
Q1 | $1.67M | Sell |
73,108
-8,220
| -10% | -$215K | 0.06% | 267 |
|
|
2024
Q4 | $2.18M | Sell |
81,328
-1,744
| -2% | -$47.3K | 0.07% | 216 |
|
|
2024
Q3 | $2.4M | Buy |
83,072
+1,836
| +2% | +$53.6K | 0.09% | 192 |
|
|
2024
Q2 | $2.55M | Buy |
81,236
+6,436
| +9% | +$177K | 0.1% | 182 |
|
|
2024
Q1 | $1.97M | Sell |
74,800
-664
| -0.9% | -$18.4K | 0.08% | 210 |
|
|
2023
Q4 | $2.14M | Sell |
75,464
-1,185
| -2% | -$35.8K | 0.1% | 187 |
|
|
2023
Q3 | $2.36M | Sell |
76,649
-1,591
| -2% | -$56.3K | 0.13% | 153 |
|
|
2023
Q2 | $2.77M | Buy |
78,240
+9,028
| +13% | +$351K | 0.14% | 142 |
|
|
2023
Q1 | $2.76M | Buy |
69,212
+5,344
| +8% | +$231K | 0.16% | 125 |
|
|
2022
Q4 | $2.78M | Buy |
63,868
+3,447
| +6% | +$165K | 0.17% | 126 |
|
|
2022
Q3 | $2.85M | Buy |
60,421
+7,998
| +15% | +$389K | 0.2% | 111 |
|
|
2022
Q2 | $2.65M | Buy |
52,423
+986
| +2% | +$50.2K | 0.19% | 107 |
|
|
2022
Q1 | $2.59M | Buy |
51,437
+209
| +0.4% | +$10.8K | 0.2% | 104 |
|
|
2021
Q4 | $2.55M | Sell |
51,228
-514
| -1% | -$25.5K | 0.18% | 110 |
|
|
2021
Q3 | $2.6M | Sell |
51,742
-1,301
| -2% | -$57.6K | 0.18% | 116 |
|
|
2021
Q2 | $2.22M | Sell |
53,043
-650
| -1% | -$25.3K | 0.16% | 122 |
|
|
2021
Q1 | $2.08M | Buy |
53,693
+2,091
| +4% | +$74.2K | 0.17% | 116 |
|
|
2020
Q4 | $1.89M | Buy |
51,602
+2,131
| +4% | +$78.2K | 0.18% | 109 |
|
|
2020
Q3 | $1.7M | Buy |
49,471
+803
| +2% | +$28.2K | 0.2% | 90 |
|
|
2020
Q2 | $1.73M | Buy |
48,668
+2,239
| +5% | +$76.1K | 0.22% | 82 |
|
|
2020
Q1 | $1.63M | Sell |
46,429
-5,273
| -10% | -$180K | 0.25% | 68 |
|
|
2019
Q4 | $1.99M | Buy |
51,702
+3,574
| +7% | +$127K | 0.25% | 72 |
|
|
2019
Q3 | $1.66M | Buy |
48,128
+869
| +2% | +$31.6K | 0.23% | 76 |
|
|
2019
Q2 | $1.92M | Sell |
47,259
-204
| -0.4% | -$8.1K | 0.28% | 71 |
|
|
2019
Q1 | $1.77M | Sell |
47,463
-5,925
| -11% | -$237K | 0.26% | 77 |
|
|
2018
Q4 | $2.14M | Sell |
53,388
-6,011
| -10% | -$250K | 0.32% | 63 |
|
|
2018
Q3 | $2.44M | Buy |
59,399
+14,081
| +31% | +$542K | 0.36% | 54 |
|
|
2018
Q2 | $1.56M | Buy |
45,318
+5,289
| +13% | +$181K | 0.24% | 72 |
|
|
2018
Q1 | $1.35M | Sell |
40,029
-115
| -0.3% | -$3.95K | 0.23% | 80 |
|
|
2017
Q4 | $1.38M | Buy |
40,144
+2,535
| +7% | +$86.4K | 0.23% | 84 |
|
|
2017
Q3 | $1.27M | Buy |
37,609
+4,519
| +14% | +$145K | 0.22% | 87 |
|
|
2017
Q2 | $1.04M | Buy |
33,090
+11,501
| +53% | +$363K | 0.27% | 73 |
|
|
2017
Q1 | $701K | Sell |
21,589
-470
| -2% | -$14.8K | 0.2% | 83 |
|
|
2016
Q4 | $680K | Sell |
22,059
-1,434
| -6% | -$43.8K | 0.25% | 76 |
|
|
2016
Q3 | $755K | Buy |
23,493
+12,749
| +119% | +$426K | 0.3% | 66 |
|
|
2016
Q2 | $359K | Buy |
10,744
+2,797
| +35% | +$89.3K | 0.17% | 82 |
|
|
2016
Q1 | $223K | Sell |
7,947
-4,163
| -34% | -$119K | 0.12% | 115 |
|
|
2015
Q4 | $371K | Buy |
12,110
+4,163
| +52% | +$131K | 0.18% | 93 |
|
|
2015
Q3 | $237K | Hold |
7,947
| – | – | 0.13% | 104 |
|
|
2015
Q2 | $253K | Sell |
7,947
-1,459
| -16% | -$47.6K | 0.12% | 115 |
|
|
2015
Q1 | $278K | Buy |
9,406
+605
| +7% | +$19.2K | 0.12% | 107 |
|
|
2014
Q4 | $260K | Buy |
+8,801
| New | +$252K | 0.11% | 100 |
|
Other funds holding PFE
Chicago Partners Investment Group's PFE Position: Q2 2026 in Review
Chicago Partners Investment Group increased its Pfizer (PFE) stake by 3.8% in Q2 2026, buying an estimated $92.7K and bringing the position to 96,817 shares worth $2.42M. The position accounts for 0.05% of the portfolio, ranked #303.
Chicago Partners Investment Group first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.85M in Q3 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Chicago Partners Investment Group held 96,817 shares of Pfizer worth $2.42M as of Q2 2026.
- Chicago Partners Investment Group bought 3,544 Pfizer shares in Q2 2026, an estimated $92.7K.
- Pfizer made up 0.05% of Chicago Partners Investment Group's portfolio in Q2 2026, its #303 holding.
- Chicago Partners Investment Group first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Chicago Partners Investment Group's Pfizer position peaked at $2.85M in Q3 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.